Andere Kunden interessierten sich auch für
![In Vitro Toxicology]( "In Vitro Toxicology")
In Vitro Toxicology81,99 €![Personalized Drug Screening for Functional Tumor Profiling]( "Personalized Drug Screening for Functional Tumor Profiling")
Personalized Drug Screening for Functional Tumor Profiling25,99 €![History of Risk Assessment in Toxicology]( "History of Risk Assessment in Toxicology")
History of Risk Assessment in Toxicology34,99 €![Klaus and Fanaroff's Care of the High-Risk Neonate]( "Klaus and Fanaroff's Care of the High-Risk Neonate")
Klaus and Fanaroff's Care of the High-Risk Neonate108,99 €![Surgical Reconstruction of the High Risk Patient, an Issue of Clinics in Podiatric Medicine and Surgery]( "Surgical Reconstruction of the High Risk Patient, an Issue of Clinics in Podiatric Medicine and Surgery")
Surgical Reconstruction of the High Risk Patient, an Issue of Clinics in Podiatric Medicine and Surgery63,99 €![Reducing Risk in Health and Social Care]( "Reducing Risk in Health and Social Care")
Reducing Risk in Health and Social Care41,99 €![Mapping Disease Transmission Risk]( "Mapping Disease Transmission Risk")
Mapping Disease Transmission Risk94,99 €
Explores the reasons for differences among leading cost-effectiveness analysis (CEA) models of CRC screening, which public health policy makers increasingly rely on to help them sift through the many choices confronting them. This book discusses the results of a collaborative pre-workshop exercise undertaken by five research teams.